{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:22:27Z","timestamp":1787836947635,"version":"build-2784847793"},"reference-count":171,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Lung Cancer (LC) continues to be the biggest cause of cancer-related deaths around the world, mostly because of delayed diagnosis. Even if tissue biopsies and circulating tumor DNA (ctDNA) tests have revolutionized clinical management of LC patients, their effectiveness is restricted in settings with lower tumor burden, molecular heterogeneity, and bias in sampling approaches. In this scenario, the epigenetic profiling of cell-free DNA (cfDNA) stands out as a promising, less invasive approach, accurately detect cancer traces. Evidence from stage I-II disease and CT-detected pulmonary nodules supports the diagnostic potential of cfDNA methylation, although further validation in prospective screening cohorts remains necessary. Beyond genomic alterations, cfDNA epigenetic changes, including DNA methylation, chromatin organization, nucleosome positioning, and fragmentation patterns, reflect multi-dimensional complexity of tumor biology. These properties convey both the functional status and the origin of the circulating DNA fragments, accelerating for tumor integrating genomic analysis. Within this group, DNA methylation is the biologically robust and clinically well-established epigenetic marker, as alterations in methylation linked to cancer often occur in the early stages of tumorigenesis and are commonly found across different cancer cell types. Here, we explored the biological and clinical relevance of the epigenetic landscape of cfDNA in LC patients, particularly focusing on DNA methylation-based biomarkers and their evolving applications towards early diagnosis and post-surgical monitoring of minimal residual disease (MRD). We aimed to comprehensively overview analytical approaches for cfDNA methylation analysis, including targeted and genome-wide profiling strategies, and discuss their integration with machine learning (ML) and multi-omics frameworks in order to improve diagnostic performance and clinical applicability in LC management.<\/jats:p>","DOI":"10.3389\/fonc.2026.1919279","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:01:50Z","timestamp":1787835710000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Epigenetic profiling of circulating cell-free DNA for early detection and minimal residual disease assessment in lung cancer: a focus on DNA methylation"],"prefix":"10.3389","volume":"16","author":[{"given":"Tancredi Didier","family":"Bazan Russo","sequence":"first","affiliation":[{"name":"Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), Section of Medical Oncology, University of Palermo","place":["Palermo, Italy"]},{"name":"Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","place":["Columbus, OH, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Gristina","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), Section of Medical Oncology, University of Palermo","place":["Palermo, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Donatello","family":"Delcuratolo","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Casa Sollievo della Sofferenza","place":["San Giovanni Rotondo, FG, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Tamburi","sequence":"additional","affiliation":[{"name":"Catholic University of the Sacred Heart","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Delli Muti","sequence":"additional","affiliation":[{"name":"Lung Cancer Research Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Casa Sollievo della Sofferenza","place":["San Giovanni Rotondo, FG, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Mangiacotti","sequence":"additional","affiliation":[{"name":"Lung Cancer Research Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Casa Sollievo della Sofferenza","place":["San Giovanni Rotondo, FG, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa","family":"Mujacic","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), Section of Medical Oncology, University of Palermo","place":["Palermo, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Fanale","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), Section of Medical Oncology, University of Palermo","place":["Palermo, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Galvano","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), Section of Medical Oncology, University of Palermo","place":["Palermo, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Gori","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella","place":["Verona, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Incorvaia","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), Section of Medical Oncology, University of Palermo","place":["Palermo, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Giordano","sequence":"additional","affiliation":[{"name":"Sbarro Institute for Cancer Research and Molecular Medicine and Center of Biotechnology, College of Science and Technology, Temple University","place":["St. Philadelphia, PA, United States"]},{"name":"Department of Medical Biotechnology, University of Siena","place":["Siena, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pepe","sequence":"additional","affiliation":[{"name":"Department of Public Health, University Federico II of Naples","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Malapelle","sequence":"additional","affiliation":[{"name":"Department of Public Health, University Federico II of Naples","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Russo","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), Section of Medical Oncology, University of Palermo","place":["Palermo, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia Anna","family":"Muscarella","sequence":"additional","affiliation":[{"name":"Lung Cancer Research Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Casa Sollievo della Sofferenza","place":["San Giovanni Rotondo, FG, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico Pio","family":"Fabrizio","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Enna \u201cKore\u201d","place":["Enna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2019.01.013","article-title":"Non-small cell lung cancer: Epidemiology, screening, diagnosis, and treatment","volume":"94","author":"Duma","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17476348.2024.2423824","article-title":"Recent advances in the use of liquid biopsy for the diagnosis and treatment of lung cancer","volume":"18","author":"Gristina","year":"2024","journal-title":"Expert Rev Respir Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1911793","article-title":"Reduced lung-cancer mortality with volume CT screening in a randomized trial","volume":"382","author":"de Koning","year":"2020","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"Aberle","year":"2011","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/nejmp2400297","article-title":"Multicancer early detection tests - Keeping a high bar for evidence of benefit","volume":"391","author":"Robbins","year":"2024","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar3247","article-title":"Detection and localization of surgically resectable cancers with a multi-analyte blood test","volume":"359","author":"Cohen","year":"2018","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-17-0716","article-title":"Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling","volume":"7","author":"Chaudhuri","year":"2017","journal-title":"Cancer Discov"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03577-y","article-title":"Molecular residual disease analysis of adjuvant osimertinib in resected EGFR-mutated stage IB-IIIA non-small-cell lung cancer","volume":"31","author":"Herbst","year":"2025","journal-title":"Nat Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2025.43.16_suppl.8009","article-title":"Association of post-surgical MRD status with neoadjuvant ctDNA dynamics, genomic mutations, and clinical outcomes in patients with resectable NSCLC (R-NSCLC) from the phase 3 AEGEAN trial","volume":"43","author":"Reck","year":"2025","journal-title":"J Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1547797","article-title":"The advances of DNA methylation in the liquid biopsy for the detection of lung cancer","volume":"15","author":"Chen","year":"2025","journal-title":"Front Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3726595","article-title":"DNA methylation as a noninvasive epigenetic biomarker for the detection of cancer","volume":"2017","author":"Leygo","year":"2017","journal-title":"Dis Markers"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1519286113","article-title":"Identification of tissue-specific cell death using methylation patterns of circulating DNA","volume":"113","author":"Lehmann-Werman","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(16)30297-2","article-title":"Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis","volume":"17","author":"Moran","year":"2016","journal-title":"Lancet Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-2025-1332","article-title":"Advances and challenges in circulating tumor DNA-based early detection of lung cancer","volume":"14","author":"Yoon","year":"2025","journal-title":"Transl Cancer Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.02.011","article-title":"Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA","volume":"31","author":"Liu","year":"2020","journal-title":"Ann Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.trecan.2019.12.006","article-title":"Diagnostic power of DNA methylation classifiers for early detection of cancer","volume":"6","author":"Roy","year":"2020","journal-title":"Trends Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"a019505","DOI":"10.1101\/cshperspect.a019505","article-title":"Epigenetic determinants of cancer","volume":"8","author":"Baylin","year":"2016","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)31268-6","article-title":"Principles of DNA methylation and their implications for biology and medicine","volume":"392","author":"Dor","year":"2018","journal-title":"Lancet"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2024.100718","article-title":"Epigenetic modifications of cfDNA in liquid biopsy for the cancer care continuum","volume":"48","author":"Wong","year":"2025","journal-title":"BioMed J"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-43624-1_7","article-title":"The role of DNA methylation in cancer","volume":"945","author":"Lakshminarasimhan","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41392-024-01848-7","article-title":"Tumor initiation and early tumorigenesis: Molecular mechanisms and interventional targets","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.3390\/diagnostics12081834","article-title":"Tracing the origin of cell-free DNA molecules through tissue-specific epigenetic signatures","volume":"12","author":"Oberhofer","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"B24","article-title":"DNA fragments in the blood plasma of cancer patients: Quantitations and evidence for their origin from apoptotic and necrotic cells","volume":"61","author":"Jahr","year":"2001","journal-title":"Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.3390\/cancers11111741","article-title":"Cell-free DNA methylation profiling analysis-technologies and bioinformatics","volume":"11","author":"Huang","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"6690","DOI":"10.1038\/s41467-024-50850-8","article-title":"DNA methylation and gene expression as determinants of genome-wide cell-free DNA fragmentation","volume":"15","author":"No\u00eb","year":"2024","journal-title":"Nat Commun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.09.006","article-title":"Cell-free DNA fragmentomics in cancer","volume":"43","author":"Tsui","year":"2025","journal-title":"Cancer Cell"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s40291-019-00390-5","article-title":"Detection of solid tumor molecular residual disease (MRD) using circulating tumor DNA (ctDNA)","volume":"23","author":"Chin","year":"2019","journal-title":"Mol Diagn Ther"},{"key":"B29","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41392-024-02021-w","article-title":"Liquid biopsy in cancer current: Status, challenges and future prospects","volume":"9","author":"Ma","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/cimb46070390","article-title":"Translation of epigenetics in cell-free DNA liquid biopsy technology and precision oncology","volume":"46","author":"Tan","year":"2024","journal-title":"Curr Issues Mol Biol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13643-025-02860-w","article-title":"Circulating cell-free DNA methylation as biomarker for lung cancer detection: A systematic review and meta-analysis of diagnostic studies","volume":"14","author":"MaChado","year":"2025","journal-title":"Syst Rev"},{"key":"B32","doi-asserted-by":"publisher","first-page":"16782","DOI":"10.1038\/s41598-021-96242-6","article-title":"A panel of DNA methylation biomarkers for detection and improving diagnostic efficiency of lung cancer","volume":"11","author":"Wei","year":"2021","journal-title":"Sci Rep"},{"key":"B33","doi-asserted-by":"publisher","first-page":"565780","DOI":"10.4236\/ojbm.2022.106149","article-title":"Performance evaluation of","volume":"10","author":"Shi","year":"2020","journal-title":"Front Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.01.032","article-title":"DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patients","volume":"147","author":"Schotten","year":"2021","journal-title":"Eur J Cancer"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.s78012","article-title":"Clinical significance of DAPK promoter hypermethylation in lung cancer: A meta-analysis","volume":"9","author":"Li","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.2147\/cmar.s174815","article-title":"Clinicopathological significance of DAPK promoter methylation in non-small-cell lung cancer: A systematic review and meta-analysis","volume":"10","author":"Zhang","year":"2018","journal-title":"Cancer Manag Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/1759-7714.12783","article-title":"P16INK4a gene promoter methylation as a biomarker for the diagnosis of non-small cell lung cancer: An updated meta-analysis","volume":"9","author":"Tuo","year":"2018","journal-title":"Thoracic Cancer"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1097\/jto.0b013e3182295745","article-title":"A comprehensive analysis of p16 expression, gene status, and promoter hypermethylation in surgically resected non-small cell lung carcinomas","volume":"6","author":"Sterlacci","year":"2011","journal-title":"J Thorac Oncol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.3390\/jcm8091500","article-title":"Subtyping lung cancer using DNA methylation in liquid biopsies","volume":"8","author":"Nunes","year":"2019","journal-title":"J Clin Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2072-1439.2015.01.24","article-title":"Methylated APC and RASSF1A in multiple specimens contribute to the differential diagnosis of patients with undetermined solitary pulmonary nodules","volume":"7","author":"Gao","year":"2015","journal-title":"J Thorac Dis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2015-0776","article-title":"SOX17 promoter methylation in plasma circulating tumor DNA of patients with non-small cell lung cancer","volume":"54","author":"Balgkouranidou","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01281","article-title":"A diagnostic panel of DNA methylation biomarkers for lung adenocarcinoma","volume":"9","author":"Shen","year":"2019","journal-title":"Front Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3233\/cbm-160321","article-title":"A systematic review of the performance of the SEPT9 gene methylation assay in colorectal cancer screening, monitoring, diagnosis and prognosis","volume":"18","author":"Song","year":"2017","journal-title":"Cancer biomark"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1186\/s12885-024-12877-4","article-title":"SEPT9: From pan-cancer to lung squamous cell carcinoma","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0703-0","article-title":"Sensitive tumour detection and classification using plasma cell-free DNA methylomes","volume":"563","author":"Shen","year":"2018","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.05.806","article-title":"Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set","volume":"32","author":"Klein","year":"2021","journal-title":"Ann Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-08-2784","article-title":"Cancer DNA methylation: Molecular mechanisms and clinical implications","volume":"15","author":"McCabe","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2021.05.002","article-title":"Navigating the DNA methylation landscape of cancer","volume":"37","author":"Nishiyama","year":"2021","journal-title":"Trends Genet"},{"key":"B49","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3390\/cancers14040961","article-title":"DNA methylation in lung cancer: Mechanisms and associations with histological subtypes, molecular alterations, and major epidemiological factors","volume":"14","author":"Hoang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B50","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3390\/ijms23020830","article-title":"CpG island methylator phenotype-a hope for the future or a road to nowhere","volume":"23","author":"Pawe\u0142","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.01.035","article-title":"5-hydroxymethylcytosine marks sites of DNA damage and promotes genome stability","volume":"14","author":"Kafer","year":"2016","journal-title":"Cell Rep"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1038\/s42003-025-09017-4","article-title":"5-hydroxymethylcytosine analysis reveals stable epigenomic changes in tumor tissue that enable cancer detection in cell-free DNA","volume":"8","author":"Xue","year":"2025","journal-title":"Commun Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2025.101830","article-title":"Epigenetic insights into minimal residual disease detection in cancer","volume":"13","author":"Ju","year":"2026","journal-title":"Genes Dis"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2022.100242","article-title":"Circulating DNA fragmentomics and cancer screening","volume":"3","author":"Thierry","year":"2023","journal-title":"Cell Genom"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2220982120","article-title":"Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifs","volume":"120","author":"Zhou","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3390\/ijms24021503","article-title":"Cell-free DNA fragmentomics: The novel promising biomarker","volume":"24","author":"Qi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.am2023-ct068","article-title":"Abstract CT068: CASCADE-LUNG: validation of a blood-based assay that evaluates cell-free DNA fragmentation patterns to detect lung cancer","volume":"83","author":"Barta","year":"2023","journal-title":"Cancer Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2404058121","article-title":"Histone modifications of circulating nucleosomes are associated with changes in cell-free DNA fragmentation patterns","volume":"121","author":"Bai","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e144561","DOI":"10.1172\/jci.insight.144561","article-title":"Circulating nuclear DNA structural features, origins, and complete size profile revealed by fragmentomics","volume":"6","author":"Sanchez","year":"2021","journal-title":"JCI Insight"},{"key":"B60","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1186\/s12864-025-12083-x","article-title":"Cell-free DNA-based inference of the activities of 370\u2009+\u2009transcription factors mirrors their activities in tumors","volume":"26","author":"Tamaki","year":"2025","journal-title":"BMC Genomics"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-022-01222-4","article-title":"Inferring gene expression from cell-free DNA fragmentation profiles","volume":"40","author":"Esfahani","year":"2022","journal-title":"Nat Biotechnol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1272-6","article-title":"Genome-wide cell-free DNA fragmentation in patients with cancer","volume":"570","author":"Cristiano","year":"2019","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-025-03624-5","article-title":"From concept to clinic: a roadmap for DNA methylation biomarkers in liquid biopsies","volume":"44","author":"Pharo","year":"2025","journal-title":"Oncogene"},{"key":"B64","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.3390\/cancers17183021","article-title":"Methylation analyses in liquid biopsy of lung cancer patients: a novel and intriguing approach against resistance to target therapies and immunotherapies","volume":"17","author":"Trombetta","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1080\/15592294.2025.2453273","article-title":"The technology landscape for detection of DNA methylation in cancer liquid biopsies","volume":"20","author":"Neefs","year":"2025","journal-title":"Epigenetics"},{"key":"B66","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12935-024-03405-2","article-title":"The common bisulfite-conversion-based techniques to analyze DNA methylation in human cancers","volume":"24","author":"Jeddi","year":"2024","journal-title":"Cancer Cell Int"},{"key":"B67","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-0716-4228-3_1","article-title":"Whole-genome bisulfite sequencing with a small amount of DNA","volume":"2873","author":"Tsutsui","year":"2025","journal-title":"Methods Mol Biol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.labinv.2024.102091","article-title":"A fast, affordable, and minimally invasive diagnostic test for cancer of unknown primary using DNA methylation profiling","volume":"104","author":"De Wilde","year":"2024","journal-title":"Lab Invest"},{"key":"B69","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13148-019-0689-y","article-title":"Comprehensive DNA methylation analysis of tissue of origin of plasma cell-free DNA by methylated CpG tandem amplification and sequencing (MCTA-Seq)","volume":"11","author":"Liu","year":"2019","journal-title":"Clin Epigenet"},{"key":"B70","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ymeth.2020.10.002","article-title":"DNA methylation methods: Global DNA methylation and methylomic analyses","volume":"187","author":"Li","year":"2021","journal-title":"Methods"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.crc-23-0564","article-title":"Noninvasive lung cancer subtype classification using tumor-derived signatures and cfDNA methylome","volume":"4","author":"Li","year":"2024","journal-title":"Cancer Res Commun"},{"key":"B72","doi-asserted-by":"publisher","first-page":"5566","DOI":"10.1038\/s41467-022-32995-6","article-title":"Cost-effective methylome sequencing of cell-free DNA for accurately detecting and locating cancer","volume":"13","author":"Stackpole","year":"2022","journal-title":"Nat Commun"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1080\/15592294.2018.1497386","article-title":"Comparison of DNA methylation measured by Illumina 450K and EPIC BeadChips in blood of newborns and 14-year-old children","volume":"13","author":"Solomon","year":"2018","journal-title":"Epigenetics"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn4030","article-title":"Heat selection enables highly scalable methylome profiling in cell-free DNA for noninvasive monitoring of cancer patients","volume":"8","author":"Cheruba","year":"2022","journal-title":"Sci Adv"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-7481-8_19","article-title":"Large-scale targeted DNA methylation analysis using bisulfite padlock probes","volume":"1708","author":"Diep","year":"2018","journal-title":"Methods Mol Biol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13148-025-01959-0","article-title":"Comprehensive comparison of enzymatic and bisulfite DNA methylation analysis in clinically relevant samples","volume":"17","author":"Nuttall","year":"2025","journal-title":"Clin Epigenet"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-019-0202-2","article-title":"Preparation of cfMeDIP-seq libraries for methylome profiling of plasma cell-free DNA","volume":"14","author":"Shen","year":"2019","journal-title":"Nat Protoc"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14252","article-title":"5-hydroxymethylcytosine profiling from genomic and cell-free DNA for colorectal cancers patients","volume":"23","author":"Gao","year":"2019","journal-title":"J Cell Mol Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40364-025-00751-9","article-title":"5-hydroxymethylcytosine modifications in circulating cell-free DNA: frontiers of cancer detection, monitoring, and prognostic evaluation","volume":"13","author":"Song","year":"2025","journal-title":"biomark Res"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2017.121","article-title":"5-hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers","volume":"27","author":"Li","year":"2017","journal-title":"Cell Res"},{"key":"B81","doi-asserted-by":"publisher","first-page":"13502","DOI":"10.1016\/j.annonc.2023.10.338","article-title":"Advances in methylation analysis of liquid biopsy in early cancer detection of colorectal and lung cancer","volume":"13","author":"Kwon","year":"2023","journal-title":"Sci Rep"},{"key":"B82","doi-asserted-by":"publisher","first-page":"40892","DOI":"10.1038\/s41598-025-24708-y","article-title":"RECAP-seq: restriction enzyme-based CpG-methylated fragment amplification for early cancer detection","volume":"15","author":"Shin","year":"2025","journal-title":"Sci Rep"},{"key":"B83","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/978-1-4939-7481-8_11","article-title":"The HELP-based DNA methylation assays","volume":"1708","author":"Greally","year":"2018","journal-title":"Methods Mol Biol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.714687","article-title":"A comparative overview of epigenomic profiling methods","volume":"9","author":"Mehrmohamadi","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1021\/prechem.5c00014","article-title":"Advances in epigenomic sequencing and their applications in cancer diagnostics","volume":"3","author":"Lin","year":"2025","journal-title":"Precis Chem"},{"key":"B86","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-025-01453-5","article-title":"Cell-type-specific subtyping of epigenomes improves prognostic stratification of cancer","volume":"17","author":"Luo","year":"2025","journal-title":"Genome Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41392-024-01823-2","article-title":"Tumor biomarkers for diagnosis, prognosis and targeted therapy","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B88","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ymeth.2020.07.006","article-title":"Targeted bisulfite sequencing for biomarker discovery","volume":"187","author":"Morselli","year":"2021","journal-title":"Methods"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-05-3408","article-title":"Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort","volume":"66","author":"Belinsky","year":"2006","journal-title":"Cancer Res"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2017.106","article-title":"5-hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages","volume":"27","author":"Song","year":"2017","journal-title":"Cell Res"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1080\/17501911.2025.2586452","article-title":"5mC and 5hmC methylation sequencing: the power of 6-base sequencing in a multiomic era","volume":"18","author":"Crawford","year":"2026","journal-title":"Epigenomics"},{"key":"B92","doi-asserted-by":"publisher","first-page":"41","DOI":"10.12688\/wellcomeopenres.17598.1","article-title":"The EWAS Catalog: a database of epigenome-wide association studies","volume":"7","author":"Battram","year":"2022","journal-title":"Wellcome Open Res"},{"key":"B93","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13059-016-1066-1","article-title":"Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling","volume":"17","author":"Pidsley","year":"2016","journal-title":"Genome Biol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41576-018-0071-5","article-title":"Current and future perspectives of liquid biopsies in genomics-driven oncology","volume":"20","author":"Heitzer","year":"2019","journal-title":"Nat Rev Genet"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1515\/almed-2025-0010","article-title":"Circulating tumor DNA in patients with cancer: insights from clinical laboratory","volume":"6","author":"Illana","year":"2025","journal-title":"Adv Lab Med"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2021-0585-cp","article-title":"Clinical testing for tumor cell-free DNA: College of American Pathologists proficiency programs reveal practice trends","volume":"147","author":"Devereaux","year":"2023","journal-title":"Arch Pathol Lab Med"},{"key":"B97","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.nbt.2023.09.005","article-title":"Interlaboratory evaluation of quality control methods for circulating cell-free DNA extraction","volume":"78","author":"Devonshire","year":"2023","journal-title":"N Bio\/Technol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"e250002","DOI":"10.6004\/jnccn.2025.0002","article-title":"NCCN Guidelines\u00ae Insights: Lung cancer screening, Version 1.2025","volume":"23","author":"Wood","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2025.08.003","article-title":"Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"36","author":"Zer","year":"2025","journal-title":"Ann Oncol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1136\/bmjonc-2024-000334","article-title":"Blood-based DNA methylation markers for lung cancer prediction","volume":"3","author":"Onwuka","year":"2024","journal-title":"BMJ Oncol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0652-7","article-title":"High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants","volume":"25","author":"Razavi","year":"2019","journal-title":"Nat Med"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1080\/01902148.2016.1214191","article-title":"Analysis of RTEL1 and PCDHGB6 promoter methylation in circulating-free DNA of lung cancer patients using liquid biopsy: A pilot study","volume":"42","author":"Powr\u00f3zek","year":"2016","journal-title":"Exp Lung Res"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-025-02026-4","article-title":"Genome-wide methylation analysis of circulating cell-free DNA identifies an episignature in lung cancer: validation of EMP2 as a potential biomarker","volume":"18","author":"Alemany-Cosme","year":"2025","journal-title":"Clin Epigenet"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1175784","article-title":"Integrative analysis of DNA methylomes reveals novel cell-free biomarkers in lung adenocarcinoma","volume":"14","author":"Chen","year":"2023","journal-title":"Front Genet"},{"key":"B105","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40364-023-00486-5","article-title":"Accurate detection of early-stage lung cancer using a panel of circulating cell-free DNA methylation biomarkers","volume":"11","author":"Hu","year":"2023","journal-title":"biomark Res"},{"key":"B106","doi-asserted-by":"publisher","first-page":"30969","DOI":"10.1038\/s41598-025-15273-5","article-title":"A prediction model based on cfDNA concentration and cfDNA methylation biomarkers for lung cancer detection","volume":"15","author":"Ke","year":"2025","journal-title":"Sci Rep"},{"key":"B107","doi-asserted-by":"publisher","first-page":"2002682","DOI":"10.1183\/13993003.02682-2020","article-title":"Validation of Lung EpiCheck, a novel methylation-based blood assay, for the detection of lung cancer in European and Chinese high-risk individuals","volume":"57","author":"Gaga","year":"2021","journal-title":"Eur Respir J"},{"key":"B108","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12931-023-02449-8","article-title":"Early detection and stratification of lung cancer aided by a cost-effective assay targeting circulating tumor DNA (ctDNA) methylation","volume":"24","author":"Wang","year":"2023","journal-title":"Respir Res"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2025.101548","article-title":"Diagnosis of early-stage non-small cell lung cancer using DNA methylation in tissue and plasma","volume":"12","author":"Li","year":"2025","journal-title":"Genes Dis"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-025-11648-4","article-title":"Lung cancer screening with low-dose CT: definition of positive, indeterminate, and negative screen results. A nodule management recommendation from the European Society of Thoracic Imaging","volume":"36","author":"Snoeckx","year":"2026","journal-title":"Eur Radiol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.7150\/thno.28119","article-title":"Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA)","volume":"9","author":"Liang","year":"2019","journal-title":"Theranostics"},{"key":"B112","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13148-020-00828-2","article-title":"Ultrasensitive DNA hypermethylation detection using plasma for early detection of NSCLC: a study in Chinese patients with very small nodules","volume":"12","author":"Chen","year":"2020","journal-title":"Clin Epigenet"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101750","article-title":"A clinically effective model based on cell-free DNA methylation and low-dose CT for risk stratification of pulmonary nodules","volume":"5","author":"Liang","year":"2024","journal-title":"Cell Rep Med"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2022.06.013","article-title":"Detection of non-metastatic non-small-cell lung cancer in urine by methylation-specific PCR analysis: A feasibility study","volume":"170","author":"Wever","year":"2022","journal-title":"Lung Cancer"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1109\/tcsi.2022.3171796","article-title":"Combination analysis of","volume":"39","author":"Park","year":"2024","journal-title":"J Korean Med Sci"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-23-1827","article-title":"Cell-free DNA methylation profile potential in the diagnosis of lung squamous cell carcinoma","volume":"16","author":"Du","year":"2024","journal-title":"J Thorac Dis"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-022-00415-9","article-title":"cfDNA methylome profiling for detection and subtyping of small cell lung cancers","volume":"3","author":"Chemi","year":"2022","journal-title":"Nat Cancer"},{"key":"B118","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00432-023-05588-z","article-title":"Detection of the DNA methylation of seven genes contribute to the early diagnosis of lung cancer","volume":"150","author":"Du","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"e145973","DOI":"10.1172\/jci145973","article-title":"Accurate diagnosis of pulmonary nodules using a noninvasive DNA methylation test","volume":"131","author":"Liang","year":"2021","journal-title":"J Clin Invest"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1177\/1073274820969703","article-title":"A novel diagnosis method based on methylation analysis of SHOX2 and serum biomarker for early stage lung cancer","volume":"27","author":"Huang","year":"2020","journal-title":"Cancer Control"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.70286","article-title":"Minimal residual disease in solid tumors: Clinical applications and future directions","volume":"132","author":"Abdo","year":"2026","journal-title":"Cancer"},{"key":"B122","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s11912-021-01131-w","article-title":"The role and impact of minimal residual disease in NSCLC","volume":"23","author":"Frisone","year":"2021","journal-title":"Curr Oncol Rep"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-024-00985-w","article-title":"Circulating tumour DNA in early stage and locally advanced NSCLC: ready for clinical implementation","volume":"22","author":"Normanno","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.12.006","article-title":"Minimal residual disease in colorectal cancer. Tumor-informed versus tumor-agnostic approaches: unraveling the optimal strategy","volume":"36","author":"Mart\u00ednez-Castedo","year":"2025","journal-title":"Ann Oncol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41698-025-00984-9","article-title":"A comprehensive overview of minimal residual disease in the management of early-stage and locally advanced non-small cell lung cancer","volume":"9","author":"Boukouris","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2025.1708518","article-title":"Liquid biopsy in cancer diagnosis and prognosis: a paradigm shift in precision oncology","volume":"12","author":"Abreu","year":"2025","journal-title":"Front Mol Biosci"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlb.2026.100462","article-title":"Harmonizing definitions in liquid biopsy: A terminology framework by the international society of liquid biopsy","volume":"12","author":"Jantus-Lewintre","year":"2026","journal-title":"J Liq Biopsy"},{"key":"B128","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12916-023-02954-z","article-title":"Individualized dynamic methylation-based analysis of cell-free DNA in postoperative monitoring of lung cancer","volume":"21","author":"Chen","year":"2023","journal-title":"BMC Med"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4339","article-title":"Potential utility of longitudinal somatic mutation and methylation profiling for predicting molecular residual disease in postoperative non-small cell lung cancer patients","volume":"10","author":"Li","year":"2021","journal-title":"Cancer Med"},{"key":"B130","first-page":"120","article-title":"Postoperative pleural fluid cell-free DNA captures locoregional MRD that stratifies risk for lung cancer relapse after surgery","author":"Earland","year":"2024"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1172108","article-title":"Minimal residual disease (MRD) detection in solid tumors using circulating tumor DNA: a systematic review","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Genet"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.am2025-3236","article-title":"Abstract 3236: Analytical validation of a tumor-agnostic DNA methylation-based assay for minimal residual disease detection in lung cancer","volume":"85","author":"Yang","year":"2025","journal-title":"Cancer Res"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.am2026-2599","article-title":"Abstract 2599: Methylation-based circulating tumor DNA predicts recurrence in definitively treated non-small cell lung cancer (NSCLC)","volume":"86","author":"Lee","year":"2026","journal-title":"Cancer Res"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.am2026-105","article-title":"Abstract 105: Quantification of circulating tumor DNA (ctDNA) in patients using cancer-specific, methylation-based, tissue-free tests for the detection of molecular residual disease (MRD)","volume":"86","author":"Parsana","year":"2026","journal-title":"Cancer Res"},{"key":"B135","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1186\/s12916-025-04419-x","article-title":"The role of dynamic monitoring of plasma cell-free DNA methylation in predicting pathological response in resectable stage IIB-IIIB non-small cell lung cancer: biomarker analyses from a prospective phase II trial","volume":"23","author":"Liu","year":"2025","journal-title":"Cancer Med"},{"key":"B136","doi-asserted-by":"publisher","first-page":"216984","DOI":"10.1016\/j.canlet.2024.216984","article-title":"Prognostic implication of methylation-based circulating tumor DNA detection prior to surgery in stage I non-small cell lung cancer","volume":"594","author":"Boss\u00e9","year":"2024","journal-title":"Cancer Lett"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2024.07.002","article-title":"Clinical utility of tumor-na\u00efve presurgical circulating tumor DNA detection in early-stage NSCLC","volume":"19","author":"Hong","year":"2024","journal-title":"J Thorac Oncol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.11.008","article-title":"Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer","volume":"35","author":"Tran","year":"2024","journal-title":"Ann Oncol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1103797","article-title":"Epigenetic liquid biopsies for minimal residual disease, what's around the corner","volume":"13","author":"Johnston","year":"2023","journal-title":"Front Oncol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/j.annonc.2026.05.100","article-title":"99P Comparison of two ddPCR-based analyses for MRD in the OPTIMISE trial (NCT04680260)","volume":"37","author":"Callesen","year":"2026","journal-title":"Ann Oncol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-022-02048-2","article-title":"Integrative analysis of multi-omics data for liquid biopsy","volume":"128","author":"Chen","year":"2023","journal-title":"Br J Cancer"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2025.101076","article-title":"Exploration of multi-omics liquid biopsy approaches for multi-cancer early detection: The PROMISE study","volume":"7","author":"Duan","year":"2026","journal-title":"Innovation (Camb)"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104553","article-title":"Multi-omics integrated circulating cell-free DNA genomic signatures enhanced the diagnostic performance of early-stage lung cancer and postoperative minimal residual disease","volume":"91","author":"Li","year":"2023","journal-title":"EBioMedicine"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1139\/bcb-2024-0004","article-title":"Chromatin- and nucleosome-associated features in liquid biopsy: implications for cancer biomarker discovery","volume":"102","author":"Penny","year":"2024","journal-title":"Biochem Cell Biol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2022.101873","article-title":"A method for early diagnosis of lung cancer from tumor originated DNA fragments using plasma cfDNA methylome and fragmentome profiles","volume":"66","author":"Kim","year":"2022","journal-title":"Mol Cell Probes"},{"key":"B146","doi-asserted-by":"publisher","first-page":"14797","DOI":"10.1038\/s41598-024-63411-2","article-title":"Deep learning model integrating cfDNA methylation and fragment size profiles for lung cancer diagnosis","volume":"14","author":"Kim","year":"2024","journal-title":"Sci Rep"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70225","article-title":"Cell-free epigenomes enhanced fragmentomics-based model for early detection of lung cancer","volume":"15","author":"Wang","year":"2025","journal-title":"Clin Transl Med"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102769","article-title":"Development and validation of an integrated system for lung cancer screening and post-screening pulmonary nodules management: a proof-of-concept study (ASCEND-LUNG)","volume":"75","author":"Jin","year":"2024","journal-title":"EClinicalMedicine"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71578","article-title":"Digital biomarkers for precision early detection of lung cancer: Integrating AI-driven multi-omics into clinical pathways","volume":"15","author":"Bu","year":"2026","journal-title":"Cancer Med"},{"key":"B150","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2174\/0113892029277397231228062412","article-title":"A novel methylation-based model for prognostic prediction in lung adenocarcinoma","volume":"25","author":"Li","year":"2024","journal-title":"Curr Genomics"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/s2589-7500(23)00125-5","article-title":"Accurate classification of pulmonary nodules by a combined model of clinical, imaging, and cell-free DNA methylation biomarkers: a model development and external validation study","volume":"5","author":"He","year":"2023","journal-title":"Lancet Digit Health"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.766","article-title":"Circulating tumor DNA methylation detection as biomarker and its application in tumor liquid biopsy: advances and challenges","volume":"5","author":"Li","year":"2024","journal-title":"MedComm (2020)"},{"key":"B153","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.3390\/cancers16112001","article-title":"Current challenges of methylation-based liquid biopsies in cancer diagnostics","volume":"16","author":"Rendek","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B154","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s12672-025-01816-9","article-title":"Next-generation sequencing in cancer diagnosis and treatment: clinical applications and future directions","volume":"16","author":"Ghoreyshi","year":"2025","journal-title":"Discov Oncol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40164-026-00760-w","article-title":"Targeting epigenetic methylation: emerging diagnosis and therapeutic strategies in cancer","volume":"15","author":"Zhu","year":"2026","journal-title":"Exp Hematol Oncol"},{"key":"B156","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1038\/s41598-019-40963-2","article-title":"DNA methylation signature of smoking in lung cancer is enriched for exposure signatures in newborn and adult blood","volume":"9","author":"Bakulski","year":"2019","journal-title":"Sci Rep"},{"key":"B157","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12916-025-04542-9","article-title":"DNA methylation-based clocks, tobacco smoking, and lung cancer risk","volume":"24","author":"Penha","year":"2025","journal-title":"BMC Med"},{"key":"B158","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.molmed.2024.03.007","article-title":"Cell-free DNA methylation in the clinical management of lung cancer","volume":"30","author":"Ezegbogu","year":"2024","journal-title":"Trends Mol Med"},{"key":"B159","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12935-023-03074-7","article-title":"Methylomics and cancer: the current state of methylation profiling and marker development for clinical care","volume":"23","author":"Liu","year":"2023","journal-title":"Cancer Cell Int"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/j.scib.2024.03.062","article-title":"Development of new techniques and clinical applications of liquid biopsy in lung cancer management","volume":"69","author":"Chen","year":"2024","journal-title":"Sci Bull (Beijing)"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1080\/17501911.2024.2340958","article-title":"Cell-free DNA methylation patterns in aging and their association with inflamm-aging","volume":"16","author":"Li","year":"2024","journal-title":"Epigenomics"},{"key":"B162","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s43856-025-01220-y","article-title":"Whole-genome profiling of age- and sex-associated DNA methylation signatures in human plasma cell-free DNA","volume":"5","author":"Chen","year":"2025","journal-title":"Commun Med (Lond)"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2023.03.005","article-title":"Epigenetic liquid biopsies: a novel putative biomarker in immunology and inflammation","volume":"44","author":"Fox-Fisher","year":"2023","journal-title":"Trends Immunol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1080\/14737159.2025.2534961","article-title":"Smaller, cheaper, faster: where next for liquid biopsies","volume":"25","author":"Gristina","year":"2025","journal-title":"Expert Rev Mol Diagn"},{"key":"B165","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s12672-026-04625-w","article-title":"The progress of biomarkers detection to lung cancer","volume":"17","author":"Qi","year":"2026","journal-title":"Discov Oncol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00874-z","article-title":"From multi-omics to deep learning: advances in cfDNA-based liquid biopsy for multi-cancer screening","volume":"14","author":"Luo","year":"2025","journal-title":"biomark Res"},{"key":"B167","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.tig.2023.01.004","article-title":"Bridging biological cfDNA features and machine learning approaches","volume":"39","author":"Moser","year":"2023","journal-title":"Trends Genet"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2022.08.011","article-title":"Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future","volume":"40","author":"Akhoundova","year":"2022","journal-title":"Cancer Cell"},{"key":"B169","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1186\/s40001-025-03003-6","article-title":"Emerging biomarkers for early cancer detection and diagnosis: challenges, innovations, and clinical perspectives","volume":"30","author":"Zafar","year":"2025","journal-title":"Eur J Med Res"},{"key":"B170","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3390\/biomedicines14010158","article-title":"Liquid biopsy in early screening of cancers: emerging technologies and new prospects","volume":"14","author":"Zhu","year":"2026","journal-title":"Biomedicines"},{"key":"B171","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13148-025-01884-2","article-title":"Recent advances on gene-related DNA methylation in cancer diagnosis, prognosis, and treatment: a clinical perspective","volume":"17","author":"Lavoro","year":"2025","journal-title":"Clin Epigenet"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1919279\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:01:53Z","timestamp":1787835713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1919279\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":171,"alternative-id":["10.3389\/fonc.2026.1919279"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1919279","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"article-number":"1919279"}}